IFNG and COVID-19: Our results evidence the involvement of the IFN-γ signaling pathway in COVID-19, pointing out a potential mechanism involved in SARS-CoV-2 infection, highlighting alternative druggable targets that may boost the host response against SARS-CoV-2.